Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2021 | 1 |
2022 | 3 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Novel strategies for the mitigation of cytokine release syndrome induced by T cell engaging therapies with a focus on the use of kinase inhibitors.
Oncoimmunology. 2022 Jun 1;11(1):2083479. doi: 10.1080/2162402X.2022.2083479. eCollection 2022.
Oncoimmunology. 2022.
PMID: 35694193
Free PMC article.
Review.
Dissecting the mechanism of cytokine release induced by T-cell engagers highlights the contribution of neutrophils.
Leclercq G, Servera LA, Danilin S, Challier J, Steinhoff N, Bossen C, Odermatt A, Nicolini V, Umaña P, Klein C, Bacac M, Giusti AM, Schneider A, Haegel H.
Leclercq G, et al.
Oncoimmunology. 2022 Feb 14;11(1):2039432. doi: 10.1080/2162402X.2022.2039432. eCollection 2022.
Oncoimmunology. 2022.
PMID: 35186442
Free PMC article.
Item in Clipboard
JAK and mTOR inhibitors prevent cytokine release while retaining T cell bispecific antibody in vivo efficacy.
Leclercq G, Haegel H, Toso A, Zimmermann T, Green L, Steinhoff N, Sam J, Pulko V, Schneider A, Giusti AM, Challier J, Freimoser-Grundschober A, Larivière L, Odermatt A, Stern M, Umana P, Bacac M, Klein C.
Leclercq G, et al.
J Immunother Cancer. 2022 Jan;10(1):e003766. doi: 10.1136/jitc-2021-003766.
J Immunother Cancer. 2022.
PMID: 35064010
Free PMC article.
Item in Clipboard
Src/lck inhibitor dasatinib reversibly switches off cytokine release and T cell cytotoxicity following stimulation with T cell bispecific antibodies.
Leclercq G, Haegel H, Schneider A, Giusti AM, Marrer-Berger E, Boetsch C, Walz AC, Pulko V, Sam J, Challier J, Ferlini C, Odermatt A, Umaña P, Bacac M, Klein C.
Leclercq G, et al.
J Immunother Cancer. 2021 Jul;9(7):e002582. doi: 10.1136/jitc-2021-002582.
J Immunother Cancer. 2021.
PMID: 34326166
Free PMC article.
Item in Clipboard
Identifying Biomarkers of Wharton's Jelly Mesenchymal Stromal Cells Using a Dynamic Metabolic Model: The Cell Passage Effect.
Laflaquière B, Leclercq G, Choey C, Chen J, Peres S, Ito C, Jolicoeur M.
Laflaquière B, et al. Among authors: leclercq g.
Metabolites. 2018 Feb 24;8(1):18. doi: 10.3390/metabo8010018.
Metabolites. 2018.
PMID: 29495309
Free PMC article.
Item in Clipboard
Cite
Cite